Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A steady diet of plastic

People eating fish are advised to watch carefully for bones, but how about tiny pieces of plastic? For years it has been known that plastic breaks down into microscopic particles that are consumed by shellfish, fish and mammals higher up the food chain, presentin...

Bob Moriarty's Thoughts on the Coronavirus

If there was ever a time for real leaders to step forward and lead, the last four months would have been the time to do so. If there was an issue that demanded cooperation from all the nations of the world, we have seen it. Instead we have been fed a steady diet of disinf...

Progress for radiology drugs and medical imaging company

Voyageur Pharmaceuticals ( TSXV:VM ) ( OTC:VYYRF ) is focused on vertically integrating the barium, iodine and carbon contrast imaging market – think radiology drugs and medical imaging. Its business plan is set to generate immediate cash flow by partnering with thir...

A ‘Novel’ Investment In Psychedelic-Inspired Medicines

Stockhouse investors are keenly aware of the booming trend in the psychedelic healthcare space…in many ways the new Cannabis 2.0 over the last 12 – 24 months. Capital markets have taken to them en masse – a market now estimated to be in excess of USD$5 billion and expected ...

A Splendid Investment Opportunity…Naturally

(Click image to play video) We’re just about smackdab in the middle of New Year’s resolution time, and millions of North Americans are committing to a healthier lifestyle or just trying to shed a few pounds. Coquitlam, BC-based...

From COVID to Nicotine Treatments, this Bio Stock is One to Watch

(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...

Arcadia Ropes in $3 Million in GoodHemp Seed Purchase Orders Within 50 Days of Product Launch

Arcadia Biosciences shares traded 25% higher after reporting that it secured $3 million in pre-season GoodHemp seed purchase commitments in just 50 days after launching the product. Arcadia Biosciences Inc. (RKDA:NASDAQ) , which employs science-based approac...

Triple Threat Canbud Launches New Products Targeting the Hottest Health & Wellness Trends

After its public listing last October, shares in Canbud Distribution Corporation (CSE: CBDX | FSE: CD0) appear poised to move higher as it executes on its three-pronged business model. Canbud is a science and technology company that concentrates its attention on the Hea...

Odd Burger, disrupting the fast food industry

Odd Burger (TSXV:ODD) is on a mission to disrupt the conventional fast food industry. The Ontario-based, entirely vegan company produces fast food made from scratch using plant-based, minimally processed and sustainable ingredients and also has nine restaurant locatio...

Could DehydraTECH CBD be Worth $3 Billion a Year to Lexaria?

PCG Digital -- Hypertension, or high blood pressure as it's commonly known, affects over three million Americans every year and is a primary or contributing cause of death for 25% of them. On a global scale, hypertension kills roughly 7.6 milli on people per year . L...
1 2 3 4 5 6 7 8 9 10 ...